Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MUC2 |
| Upstream (Parents) |
|---|
| (<<) CASP3 → MUC2 |
| (<<) CASP7 → MUC2 |
| (<<) CREB3L1 → MUC2 |
| (<<) ENO3 → MUC2 |
| (<<) HDAC11 → MUC2 |
| (<<) HMGCR → MUC2 |
| (<<) IL1R2 → MUC2 |
| (<<) ITGB8 → MUC2 |
| (<<) JAK2 → MUC2 |
| (<<) MERTK → MUC2 |
| (<<) MST1R → MUC2 |
| (<<) NAV2 → MUC2 |
| (<<) PRSS2 → MUC2 |
| (<<) RPA4 → MUC2 |
| (<<) SERPINB5 → MUC2 |
| (<<) SPDEF → MUC2 |
| (<<) STAT4 → MUC2 |
| (<<) TFF1 → MUC2 |
| (<<) TSPO → MUC2 |
| (<<) VPS37B → MUC2 |
| Downstream (Children) |
|---|
| MUC2 → CLCA4 (>>) |
| MUC2 → GLS (>>) |
| MUC2 → JAK3 (>>) |
| MUC2 → PLA2G3 (>>) |
| MUC2 → TPSG1 (>>) |
